Stanza Living certified Safe Place to Stay by Equinox Labs
OnStanza Living, India The company has also received a Equinox Labs, which carried out comprehensive checks on the company According to the company, to.
Read More
Stellaris closes 2nd fund at USD 225mn, to make 25-30 seed, Series A investments
OnEarly-stage venture capital firm Stellaris Venture Partners on Wednesday announced the closing of its second fund at USD 225 million (about Rs 1,675.5 crore).
Read More
NTPC invites EOI to set up pilot project on hydrogen blending with natural gas
OnState-run NTPC has invited global expression of interest to set up a pilot project on hydrogen blending with natural gas in city gas distribution..
Read More
Life Insurance: Lock in annuity rate with Saral Pension
OnAfter the insurance regulator The single premium, non-linked, non-participating, individual immediate annuity plan offers lifelong guaranteed rates, right at the time of purchase which.
Read More
Economy first: Current focus on growth for sure, says Finance minister Nirmala Sitharaman
OnFinance minister Nirmala Sitharaman made it unambiguous on Thursday that economic growth was the first priority of the government right now and thanked the.
Read More
Tata Power profit zooms 74% to Rs 465 crore in April-June quarter
OnTata Powers consolidated net profit jumped nearly 74 per cent to Rs 465.69 crore in the April-June quarter of 2021 compared to Rs 268.10.
Read More
Cloud Benefits: Oracle opens cloud benefits to India’s public sector
OnJust over a year after bringing the Oracle public cloud to India by establishing cloud regions in Mumbai and Hyderabad, Oracle announced that it.
Read More
Inflation likely to stabilise rest of the year: RBI’s August bulletin
OnInflation is set to follow the trajectory anticipated by the central bank and may stabilise during the rest of the current financial year, executives.
Read More
Gas pipelines: Cheaper energy basket in offing
OnWith the country aiming to increase the share of gas in its energy basket to 15% by 2030 from the current level of 6%,.
Read More
Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
OnDrug major Aurobindo Pharma is looking to commercialise a COVID-19 vaccine, build a portfolio of biosimilar products, expand API production as part of its.
Read More